Annual FCF
$21.84 M
+$94.84 M+129.93%
December 31, 2023
Summary
- As of February 23, 2025, PRQR annual free cash flow is $21.84 million, with the most recent change of +$94.84 million (+129.93%) on December 31, 2023.
- During the last 3 years, PRQR annual FCF has risen by +$76.64 million (+139.86%).
- PRQR annual FCF is now at all-time high.
Performance
PRQR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$7.05 M
-$178.60 K-2.60%
September 1, 2024
Summary
- As of February 23, 2025, PRQR quarterly free cash flow is -$7.05 million, with the most recent change of -$178.60 thousand (-2.60%) on September 1, 2024.
- Over the past year, PRQR quarterly FCF has increased by +$1.55 million (+17.99%).
- PRQR quarterly FCF is now -114.73% below its all-time high of $47.89 million, reached on March 31, 2023.
Performance
PRQR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$37.73 M
+$1.55 M+3.94%
September 1, 2024
Summary
- As of February 23, 2025, PRQR TTM free cash flow is -$37.73 million, with the most recent change of +$1.55 million (+3.94%) on September 1, 2024.
- Over the past year, PRQR TTM FCF has dropped by -$44.93 million (-624.15%).
- PRQR TTM FCF is now -272.74% below its all-time high of $21.84 million, reached on December 31, 2023.
Performance
PRQR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
PRQR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +129.9% | +18.0% | -624.1% |
| 3 y3 years | +139.9% | +48.4% | +20.9% |
| 5 y5 years | +164.2% | +48.4% | +20.9% |
PRQR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +129.9% | -114.7% | +69.7% | -272.7% | +48.3% |
| 5 y | 5-year | at high | +129.9% | -114.7% | +69.7% | -272.7% | +48.3% |
| alltime | all time | at high | +129.9% | -114.7% | +69.7% | -272.7% | +48.3% |
ProQR Therapeutics NV Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.05 M(+2.6%) | -$37.73 M(-3.9%) |
| Jun 2024 | - | -$6.87 M(-60.1%) | -$39.28 M(-9.2%) |
| Mar 2024 | - | -$17.23 M(+162.1%) | -$43.28 M(-298.1%) |
| Dec 2023 | $21.84 M(-129.9%) | -$6.57 M(-23.5%) | $21.84 M(+203.4%) |
| Sep 2023 | - | -$8.60 M(-20.9%) | $7.20 M(+236.1%) |
| Jun 2023 | - | -$10.87 M(-122.7%) | $2.14 M(-214.9%) |
| Mar 2023 | - | $47.89 M(-325.7%) | -$1.86 M(-97.4%) |
| Dec 2022 | -$72.99 M(+132.8%) | -$21.22 M(+55.4%) | -$72.99 M(+53.1%) |
| Sep 2022 | - | -$13.66 M(-8.2%) | -$47.69 M(+10.5%) |
| Jun 2022 | - | -$14.88 M(-36.0%) | -$43.17 M(+6.9%) |
| Mar 2022 | - | -$23.24 M(-668.5%) | -$40.38 M(+28.8%) |
| Dec 2021 | -$31.35 M(-42.8%) | $4.09 M(-144.7%) | -$31.35 M(-34.7%) |
| Sep 2021 | - | -$9.14 M(-24.4%) | -$48.01 M(-8.4%) |
| Jun 2021 | - | -$12.09 M(-14.9%) | -$52.43 M(+0.4%) |
| Mar 2021 | - | -$14.21 M(+13.0%) | -$52.23 M(-4.7%) |
| Dec 2020 | -$54.80 M(+9.9%) | -$12.57 M(-7.2%) | -$54.80 M(-2.4%) |
| Sep 2020 | - | -$13.55 M(+13.9%) | -$56.12 M(+7.7%) |
| Jun 2020 | - | -$11.89 M(-29.1%) | -$52.09 M(-0.5%) |
| Mar 2020 | - | -$16.78 M(+20.7%) | -$52.35 M(+5.0%) |
| Dec 2019 | -$49.87 M | -$13.90 M(+46.0%) | -$49.87 M(+5.9%) |
| Sep 2019 | - | -$9.52 M(-21.7%) | -$47.11 M(+11.7%) |
| Jun 2019 | - | -$12.16 M(-15.0%) | -$42.18 M(+15.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$14.30 M(+28.4%) | -$36.38 M(+7.0%) |
| Dec 2018 | -$34.01 M(-14.4%) | -$11.13 M(+142.8%) | -$34.01 M(+7.6%) |
| Sep 2018 | - | -$4.59 M(-27.9%) | -$31.62 M(-15.5%) |
| Jun 2018 | - | -$6.36 M(-46.7%) | -$37.41 M(-11.4%) |
| Mar 2018 | - | -$11.93 M(+36.5%) | -$42.25 M(+6.4%) |
| Dec 2017 | -$39.72 M(-2.4%) | -$8.75 M(-15.7%) | -$39.72 M(+2.2%) |
| Sep 2017 | - | -$10.38 M(-7.3%) | -$38.86 M(-4.6%) |
| Jun 2017 | - | -$11.19 M(+19.0%) | -$40.75 M(-0.5%) |
| Mar 2017 | - | -$9.40 M(+19.3%) | -$40.97 M(+0.7%) |
| Dec 2016 | -$40.68 M(+43.5%) | -$7.88 M(-35.8%) | -$40.68 M(+0.4%) |
| Sep 2016 | - | -$12.27 M(+7.5%) | -$40.51 M(+14.6%) |
| Jun 2016 | - | -$11.41 M(+25.1%) | -$35.35 M(+14.1%) |
| Mar 2016 | - | -$9.12 M(+18.3%) | -$30.98 M(+9.2%) |
| Dec 2015 | -$28.36 M(+35.9%) | -$7.71 M(+8.6%) | -$28.36 M(+0.7%) |
| Sep 2015 | - | -$7.10 M(+0.8%) | -$28.17 M(+4.4%) |
| Jun 2015 | - | -$7.04 M(+8.3%) | -$26.97 M(+10.1%) |
| Mar 2015 | - | -$6.50 M(-13.5%) | -$24.50 M(+17.4%) |
| Dec 2014 | -$20.87 M(+536.3%) | -$7.52 M(+27.4%) | -$20.87 M(+56.3%) |
| Sep 2014 | - | -$5.90 M(+28.9%) | -$13.35 M(+79.3%) |
| Jun 2014 | - | -$4.58 M(+59.7%) | -$7.44 M(+159.7%) |
| Mar 2014 | - | -$2.87 M | -$2.87 M |
| Dec 2013 | -$3.28 M | - | - |
FAQ
- What is ProQR Therapeutics NV annual free cash flow?
- What is the all time high annual FCF for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual FCF year-on-year change?
- What is ProQR Therapeutics NV quarterly free cash flow?
- What is the all time high quarterly FCF for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV quarterly FCF year-on-year change?
- What is ProQR Therapeutics NV TTM free cash flow?
- What is the all time high TTM FCF for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV TTM FCF year-on-year change?
What is ProQR Therapeutics NV annual free cash flow?
The current annual FCF of PRQR is $21.84 M
What is the all time high annual FCF for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual free cash flow is $21.84 M
What is ProQR Therapeutics NV annual FCF year-on-year change?
Over the past year, PRQR annual free cash flow has changed by +$94.84 M (+129.93%)
What is ProQR Therapeutics NV quarterly free cash flow?
The current quarterly FCF of PRQR is -$7.05 M
What is the all time high quarterly FCF for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly free cash flow is $47.89 M
What is ProQR Therapeutics NV quarterly FCF year-on-year change?
Over the past year, PRQR quarterly free cash flow has changed by +$1.55 M (+17.99%)
What is ProQR Therapeutics NV TTM free cash flow?
The current TTM FCF of PRQR is -$37.73 M
What is the all time high TTM FCF for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high TTM free cash flow is $21.84 M
What is ProQR Therapeutics NV TTM FCF year-on-year change?
Over the past year, PRQR TTM free cash flow has changed by -$44.93 M (-624.15%)